Precipio, Inc.

PRPO · Nasdaq · SIC 3826: Laboratory Analytical Instruments
402
SEC Filings

Business Summary

Precipio, Inc. is a healthcare biotechnology company focused on improving cancer diagnostics, particularly hematologic malignancies. The company operates two divisions: a Pathology Services Division providing specialized cancer diagnostic testing (molecular diagnostics, cytogenetics) to physicians, hospitals, and laboratories; and a Products Division that develops and commercializes proprietary diagnostic assays and kits for use by other clinical laboratories. Its integrated R&D model uses clinical lab operations to develop and validate diagnostic products at incremental cost.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPRPOdiscussed_in_filing Cybersecurity
topic_mentionPRPOdiscussed_in_filing Trusted Computing
topic_mentionPRPOdiscussed_in_filing Blockchain & Crypto
topic_mentionPRPOdiscussed_in_filing Capital Expenditure
topic_mentionPRPOdiscussed_in_filing Supply Chain
topic_mentionPRPOdiscussed_in_filing Regulation
topic_mentionPRPOdiscussed_in_filing Healthcare & Bio
topic_mentionPRPOdiscussed_in_filing AI Compute
topic_mentionPRPOdiscussed_in_filing Platform & Ecosystem
topic_mentionPRPOdiscussed_in_filing Sovereign & Government
topic_mentionPRPOdiscussed_in_filing Cybersecurity
topic_mentionPRPOdiscussed_in_filing Trusted Computing
topic_mentionPRPOdiscussed_in_filing Blockchain & Crypto
topic_mentionPRPOdiscussed_in_filing Capital Expenditure
topic_mentionPRPOdiscussed_in_filing Supply Chain
topic_mentionPRPOdiscussed_in_filing Regulation
topic_mentionPRPOdiscussed_in_filing Healthcare & Bio
topic_mentionPRPOdiscussed_in_filing AI Compute
topic_mentionPRPOdiscussed_in_filing Platform & Ecosystem
topic_mentionPRPOdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001104659-26-036878EDGAR63K words
2025-03-272024-12-310001558370-25-003817EDGAR—
2024-03-292023-12-310001558370-24-004365EDGAR—
2023-03-302022-12-310001558370-23-005076EDGAR—
2022-03-302021-12-310001558370-22-004774EDGAR—
2021-03-292020-12-310001558370-21-003619EDGAR—
2020-03-272019-12-310001558370-20-003247EDGAR—
2019-04-162018-12-310001558370-19-003039EDGAR—
2018-04-132017-12-310001144204-18-020539EDGAR—
2017-04-132016-12-310001043961-17-000005EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001104659-25-112601EDGAR22K words
2025-08-132025-06-300001558370-25-011390EDGAR—
2025-05-142025-03-310001558370-25-007776EDGAR—
2024-11-062024-09-300001558370-24-014619EDGAR—
2024-08-132024-06-300001558370-24-012053EDGAR—
2024-05-142024-03-310001558370-24-008128EDGAR—
2023-11-132023-09-300001558370-23-018820EDGAR—
2023-08-112023-06-300001558370-23-014655EDGAR—
2023-05-122023-03-310001558370-23-009597EDGAR—
2022-11-102022-09-300001558370-22-017400EDGAR—
2022-08-112022-06-300001558370-22-013260EDGAR—
2022-05-112022-03-310001558370-22-008317EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001104659-26-021625EDGAR1K words
2025-12-290001104659-25-124902EDGAR—
2025-11-060001104659-25-107708EDGAR—
2025-09-030001104659-25-086995EDGAR—
2025-08-180001104659-25-079859EDGAR—
2025-07-310001104659-25-072760EDGAR—
2025-06-170001104659-25-060236EDGAR—
2025-05-150001104659-25-049371EDGAR—
2025-05-060001104659-25-045024EDGAR—
2025-04-100001104659-25-033457EDGAR—

402 total filings indexed. 370 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

TXG — 10x Genomics, Inc. A — AGILENT TECHNOLOGIES, INC. ASTC — ASTROTECH Corp AVTR — Avantor, Inc. BIO — BIO-RAD LABORATORIES, INC. BFNH — BIOFORCE NANOSCIENCES HOLDINGS, INC. BRKR — BRUKER CORP BNGO — Bionano Genomics, Inc.

Tags

oncology-diagnostics hematologic-malignancies clinical-laboratory-services healthcare-biotechnology u.s.-clinical-laboratory-improvement-act-of-1967 u.s.-clinical-laboratory-improvement-amendments-of-1988 european-union-in-vitro-diagnostics-regulation

Company Identity

CIK0001043961
TickerPRPO
ExchangeNasdaq
SIC3826: Laboratory Analytical Instruments
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 43b306474b9599ecda3f7dcfafb9bce290bc1b0b81e71a94528a99e8a6290158
parent: 0febf46ee032d5a7cc2af9b79e7f5d7f01d08dd8d21323a60d41f36f3353c45b
content hash: a4b3c1514a1bcb794084f1086116e126cceb12ab69d7529d87d06d67410b5939
signed: 2026-04-13T04:47:00.729Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf